Emcure Pharmaceuticals Ltd (EMCURE)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1383.30
% Change: 2.47% (Prev Close: 1350.00)

Volume: 55,376
% Change: -4.25% (Prev Volume: 57,836)

Delivery: 30,875
Delivery % : 55.76
% Change: 11.68% (Prev Delivery: 27,645)

Turnover: 763 Lacs
% Change: -3.38% (Prev Turnover: 790)

πŸ’Ή EOD Valuation

P/E Ratio: 35.20
P/B Ratio: 5.90
Market Cap: 26214 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: EMCURE
Market Cap: 26406 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 1580.00
52 Week Low: 889.00

All-Time High: 1580.00 Rs.
All-Time Low: 889.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-4.36% | 3.31% | 41.29% | -2.77% | 0.00%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 77.91%

Change (3Y | 1Y): 0.00% | -0.01%

Pledged %: 0.04%

FII Holding

FII Holding: 2.86%

Change (3Y | 1Y): 0.00% | -0.20%

DII Holding

DII Holding: 2.84%

Change (3Y | 1Y): 0.00% | -0.60%

Public Holding: 16.39%

🏦 Financial Strength

Debt to Equity: 0.23
Debt: 1022.75 Rs. Cr.

Book Value: 234.65 Rs.
Current Ratio: 1.68
Interest Coverage: 8.43
Free Cash Flow: 475.38 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 18.28%

Sales Growth Qtr (YOY | QoQ):
15.72% | -0.74%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.36% | 10.48% | 18.28%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 45.46%

Profit Growth Qtr (YOY | QoQ):
45.28% | 8.90%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
36.07% | 1.10% | 45.46%

EPS Rs.

EPS (TTM): 39.30 Rs.

EPS Qtr (Last Year | Latest):
7.95 Rs. | 10.92 Rs.

EPS Annual (Last Annual | Annual March):
27.50 Rs. | 35.96 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
34.81% | -0.46%

Net Profit Rs. Cr.

Net Profit (TTM): 769.67 Rs. Cr.

Net Profit (Annual - March): 707.47 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
152.59| 197.24 | 214.79

EBITDA Rs. Cr.

EBITDA (Quarter): 420.47 Rs. Cr.
EBITDA (Previous Yr Ql): 359.76 Rs. Cr.

EBITDA (Annual - March): 1536.16 Rs. Cr.
EBITDA (Previous Annual): 1284.41 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
14.21% | 3.30%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 19.09%

OPM Qtr (Previous | Current):
19.02% | 19.84%

OPM Annual (5 Yrs | Last Yr | March):
20.45% | 18.47% | 18.60%

Return on Equity %

ROE: 18.51%

ROE (5 Yrs | 3 Yrs | Last Yr):
21.78% | 19.89% | 18.46%

Return on Capital Employed %

ROCE: 20.72%

ROCE (5 Yrs | 3 Yrs | Last Yr):
21.57% | 20.03% | 18.62%

Return on Assets %

ROA (TTM): 8.98%

ROA (5 Yrs | 3 Yrs | Last Yr):
8.60% | 8.46% | 7.43%

PEG Ratio: 31.88
Dividend Yield: 0.22%

PE 3 Yrs: 44.24
PE 5 Yrs: 44.24

Dividend Yield: 0.22%

πŸ‘₯ Company

Emcure Pharmaceuticals Ltd

EMCURE

Promoter Holding: %